FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Inquirer on MSN1h
US approves first-ever obstructive sleep apnea drug
On December 20, 2024, pharmaceutical company Eli Lilly announced that the FDA approved its first and only obstructive sleep ...
punjabnewsexpress22h
Eli Lilly’s Zepbound drug likely to dominate global obesity market: Report
Eli Lilly’s Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...
The Financial Express16h
Eli Lilly’s Zepbound holds potential to dominate obesity market
Given Wegovy’s success and record-high sales, a wave of investments has gone into the obesity space over the last couple of ...
The New York Times18h
World News
The Houthis, an Iranian-backed group based in Yemen, have launched repeated attacks despite the Israeli military’s retaliatory airstrikes. By Adam Rasgon Stepped up attacks by Russia are ...
cryptonews15h
Latest Crypto News
New York Judge Delays Start of Trial Between CFTC and Gemini Trust Company ...